2NVS : FDA OKs Novartis Prostate Cancer Treatment, Triples Eligible Patient Pool
In the study, Pluvicto (lutetium Lu 177 vipivotide tetraxetan) reduced the risk of radiographic progression or death by 59% ...
Campaign for men to check prostate cancer risk
A campaign has been launched to encourage more men to check their prostate cancer risks. According to Barnsley Metropolitan ...
Colin Egglesfield Recalls Secretly Feeling 'Weak and Sweaty' from Cancer Treatment on the Set of All My Children
Colin Egglesfield shared that he hid his cancer from his 'All My Children' colleagues until he "broke down" on set.
TBX2 protein acts as a switch to drive prostate cancer treatment resistance, study finds
According to the American Cancer Society, approximately 1 in 8 men in the U.S. will be diagnosed with prostate cancer during ...
Healio4h
FDA expands Pluvicto indication for earlier use in patients with prostate cancer
The FDA approved a radioligand therapy for earlier use prior to chemotherapy in patients with prostate-specific membrane ...
Prostate cancer risk increases by 45% among men who share one troubling behavior
A new study has revealed that men who don't heed recommendations for prostate cancer screenings are at a significantly higher ...
Medical News Today1d
Going to screenings may lower death risk from prostate cancer by 23%
Men who avoided prostate cancer screening appointments were significantly more likely to die from the disease, according to ...
MHRA approves trofolastat for prostate cancer diagnostic imaging
Trofolastat is a prostate-specific membrane antigen-targeting agent cleared for use with Technetium-99m for cancerous lesion ...